$FRNM News

Freenome Unveils SimpleScreen Lung Enabling Patients To Be Screened For Lung And Colorectal Cancer Through Single Blood Draw, Using Two Independently Validated, Indication-Specific Tests

Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition

Guggenheim Initiates Coverage On Freenome with Buy Rating, Announces Price Target of $21

Frenome Files Prospectus Related To The Offer And Sale From Time To Time By The Selling Securityholders Of Up To 75,188,742 Shares Of Common Stock

TD Cowen Initiates Coverage On Freenome with Buy Rating, Announces Price Target of $17

Jefferies Initiates Coverage On Freenome with Buy Rating, Announces Price Target of $17

BTIG Initiates Coverage On Freenome with Buy Rating, Announces Price Target of $17

Leerink Partners Initiates Coverage On Freenome with Outperform Rating, Announces Price Target of $18

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Freenome Receives FDA Breakthrough Device Designation For Its Investigational Lung Cancer Screening Test SimpleScreen Lung

Freenome (FRNM) Climbed, But What Is Driving Attention Now?

Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test.

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Perceptive Capital Q2 EPS $(0.01) Down From $0.07 YoY

Perceptive Capital, Freenome Holdings Announce Their Form S-4 Registration Regarding Proposed Merger Declared Effective By U.S. SEC; Business Combination Expected To Be Completed In July

Perceptive Capital Q1 EPS $0.00 Down From $0.06 YoY

Perceptive Capital Solutions shares are trading higher after the company and Freenome Holdings announced a definitive business combination agreement.

Perceptive Capital Solutions shares are trading higher after the company and Freenome Holdings announced a definitive business combination agreement.

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform

Freenome Holdings Enters Into Definitive Business Combination Agreement With Capital Solutions Corp; PCSC Renamed Freenome Under Ticker 'FRNM'